$9.810
-0.493 (-5.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ZVRA Prediction & Forecast by Similar Chart Analysis
Alphio's ZVRA stock price prediction model matches the current Zevra Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.67 (-1.44%). The 1-week path is $9.39 (-4.30%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Zevra Therapeutics Inc Stock?
Currently, Zevra Therapeutics Inc (ZVRA) is trading at $9.94, which is significantly below the analyst price targets of $23 and $28. However, the stock has a low RSI of 26.949, indicating it is oversold, and it has experienced a 12.73% decline over the past five days. The company reported a strong Q2 2026 with a 53% year-over-year revenue increase to $39.7 million, but faces regulatory challenges in Europe. The main risk is the recent rejection of its drug application by the EMA, which could impact future revenue growth.
ZVRA stock price ended at $9.81 on Friday, after losing -5.03%
Zevra Therapeutics Inc (ZVRA) last closed at $9.81, losing -5.03%. These facts feed the 1-day and 1-week ZVRA price prediction above.
Forecast Drivers
Zevra Therapeutics Inc (ZVRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ZVRA, ranked by similarity.
Seasonality analysis for ZVRA
Historically the probability of a positive October return for ZVRA is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ZVRA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $16.02 | $17.58 | $24.15 | +79.21% |
| Nov 2026 | $12.14 | $17.17 | $24.99 | +75.02% |
| Dec 2026 | $20.43 | $23.43 | $26.57 | +138.83% |
In 2026, Zevra Therapeutics Inc (ZVRA) is projected to range from $12.14 to $26.57.
Zevra Therapeutics Inc 2026 monthly forecast
In Oct 2026, Zevra Therapeutics Inc is projected to average $17.58, with a low of $16.02 and high of $24.15.
In Nov 2026, Zevra Therapeutics Inc is projected to average $17.17, with a low of $12.14 and high of $24.99.
In Dec 2026, Zevra Therapeutics Inc is projected to average $23.43, with a low of $20.43 and high of $26.57.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.